-
公开(公告)号:US20110077251A1
公开(公告)日:2011-03-31
申请号:US12856848
申请日:2010-08-16
申请人: Christophe Moinet , Bingcan Liu , Liliane Halab , Nathalie Turcotte , Real Denis , Carl Poisson , Paul Nguyen-Ba , Monica Bubenik , Laval Chan Chun Kong
发明人: Christophe Moinet , Bingcan Liu , Liliane Halab , Nathalie Turcotte , Real Denis , Carl Poisson , Paul Nguyen-Ba , Monica Bubenik , Laval Chan Chun Kong
IPC分类号: A61K31/5375 , C07C271/24 , C07C69/34 , C07D295/195 , C07C69/74 , C07D211/60 , C07D211/32 , C07D271/113 , C07D277/46 , C07D309/06 , C07D213/75 , C07D207/04 , C07D231/14 , A61K31/215 , A61K31/495 , A61K31/4453 , A61K31/4245 , A61K31/426 , A61K31/351 , A61K31/4409 , A61K31/40 , A61K31/415 , A61P31/18
摘要: The invention relates to 17β lupane derivatives of formula (I): wherein R1 and X are as defined herein, and pharmaceutically acceptable salts and solvates thereof. These compounds exhibit significant anti-HIV activity. Thus, the invention also relates to methods for prevention or treatment of HIV infection by administering therapeutically effective amounts of a compound of formula (I), or a pharmaceutically acceptable salt or solvate thereof to a subject in need of such treatment.
摘要翻译: 本发明涉及17&bgr; 式(I)的十二烷衍生物:其中R 1和X如本文所定义,及其药学上可接受的盐和溶剂化物。 这些化合物显示出显着的抗HIV活性。 因此,本发明还涉及通过向需要这种治疗的受试者施用治疗有效量的式(I)化合物或其药学上可接受的盐或溶剂合物来预防或治疗HIV感染的方法。
-
公开(公告)号:US08269026B2
公开(公告)日:2012-09-18
申请号:US12830293
申请日:2010-07-03
申请人: Christophe Moinet , Liliane Halab , Nathalie Turcotte , Monica Bubenik , Marc Courchesne , Carl Poisson , Oswy Z. Pereira , Paul Nguyen-Ba , Bingcan Liu , Nathalie Chauret , Caroline Cadilhac , Laval Chan Chun Kong
发明人: Christophe Moinet , Liliane Halab , Nathalie Turcotte , Monica Bubenik , Marc Courchesne , Carl Poisson , Oswy Z. Pereira , Paul Nguyen-Ba , Bingcan Liu , Nathalie Chauret , Caroline Cadilhac , Laval Chan Chun Kong
IPC分类号: C07J53/00
CPC分类号: C07J63/008
摘要: The invention relates to 21-keto triterpene compounds of formula (I): wherein R1, X, and Y are as defined herein, and pharmaceutically acceptable salts and solvates thereof. These compounds exhibit significant anti-HIV activity. Thus, the invention also relates to methods for prevention or treatment of HIV infections by administering therapeutically effective amounts of a compound of formula (I), or a pharmaceutically acceptable salt or solvate thereof to a subject in need of such treatment.
摘要翻译: 本发明涉及式(I)的21-酮三萜化合物:其中R 1,X和Y如本文所定义,及其药学上可接受的盐和溶剂化物。 这些化合物显示出显着的抗HIV活性。 因此,本发明还涉及通过向需要这种治疗的受试者施用治疗有效量的式(I)化合物或其药学上可接受的盐或溶剂合物来预防或治疗HIV感染的方法。
-
公开(公告)号:US20110077227A1
公开(公告)日:2011-03-31
申请号:US12830293
申请日:2010-07-03
申请人: Christophe Moinet , Liliane Halab , Nathalie Turcotte , Monica Bubenik , Marc Courchesne , Carl Poisson , Oswy Z. Pereira , Paul Nguyen-Ba , Bingcan Liu , Nathalie Chauret , Caroline Cadilhac , Laval Chan Chun Kong
发明人: Christophe Moinet , Liliane Halab , Nathalie Turcotte , Monica Bubenik , Marc Courchesne , Carl Poisson , Oswy Z. Pereira , Paul Nguyen-Ba , Bingcan Liu , Nathalie Chauret , Caroline Cadilhac , Laval Chan Chun Kong
IPC分类号: C07J53/00 , A61K31/565 , A61K31/58 , A61K31/566 , A61P31/18
CPC分类号: C07J63/008
摘要: The invention relates to 21-keto triterpene compounds of formula (I): wherein R1, X, and Y are as defined herein, and pharmaceutically acceptable salts and solvates thereof. These compounds exhibit significant anti-HIV activity. Thus, the invention also relates to methods for prevention or treatment of HIV infections by administering therapeutically effective amounts of a compound of formula (I), or a pharmaceutically acceptable salt or solvate thereof to a subject in need of such treatment.
摘要翻译: 本发明涉及式(I)的21-酮三萜化合物:其中R 1,X和Y如本文所定义,及其药学上可接受的盐和溶剂合物。 这些化合物显示出显着的抗HIV活性。 因此,本发明还涉及通过向需要这种治疗的受试者施用治疗有效量的式(I)化合物或其药学上可接受的盐或溶剂合物来预防或治疗HIV感染的方法。
-
公开(公告)号:US06350753B1
公开(公告)日:2002-02-26
申请号:US09163374
申请日:1998-09-30
申请人: Bernard Belleau , Dilip M. Dixit , Paul Nguyen-Ba
发明人: Bernard Belleau , Dilip M. Dixit , Paul Nguyen-Ba
IPC分类号: C07D40504
CPC分类号: C07D327/04 , C07D405/04 , C07D411/04 , C07D411/14 , C07D473/00 , C07D473/40
摘要: Nucleoside analogues containing a 1,3-dioxolane structure are suitable antiviral agents, particulary for the treatment of the HIV infections in mammals, especially humans. Examples of the nucleoside analogues include: cis-2-acetoxymethyl-4-(thymin-1′-yl)-1,3,-dioxolane, cis-2-hydroxymethyl-4-(thymin-1′-yl)-1,3-dioxolane, cis-2-benzoyloxymethyl-4-(cytosin-1′-yl)-1,3-dioxolane, and cis-2-hydroxymethyl-4-(cytosin-1′-yl)-1,3-dioxolane. These compounds can be in the form of their racemates or their separate enantiomers.
摘要翻译: 含有1,3-二氧戊环结构的核苷类似物是合适的抗病毒剂,特别是用于治疗哺乳动物尤其是人的HIV感染。 核苷类似物的实例包括顺式-2-乙酰氧基甲基-4-(甲氨基-1'-基)-1,3, - 二氧杂环戊烷,顺式-2-羟甲基-4-(甲氨基-1'-基) 顺式-2-苯甲酰氧基甲基-4-(细胞蛋白酶-1'-基)-1,3-二氧戊环,和顺-2-羟甲基-4-(胞嘧啶-1'-基)-1,3-二氧戊环。 这些化合物可以是它们的外消旋物或其单独的对映异构体的形式。
-
公开(公告)号:US5945431A
公开(公告)日:1999-08-31
申请号:US923604
申请日:1997-09-04
申请人: Haolun Jin , Laval C. Chan , Wei Wang , Tomislav Stefanac , Tarek S. Mansour , Paul Nguyen-Ba , Jean-Francois Lavallee , Guy Falardeau
发明人: Haolun Jin , Laval C. Chan , Wei Wang , Tomislav Stefanac , Tarek S. Mansour , Paul Nguyen-Ba , Jean-Francois Lavallee , Guy Falardeau
IPC分类号: C07D215/48 , C07D471/04 , A61K31/435
CPC分类号: C07D471/04 , C07D215/48
摘要: The present invention relates to heterocyclic compounds having antiviral activity. In particular, compounds of formula (I): wherein B, W, X, Y, R.sub.1, R.sub.2, R.sub.3, R.sub.4 and n are as defined herein, are useful in the therapy and prophylaxis of cytomegalovirus (CMV) infection in mammals.
摘要翻译: 本发明涉及具有抗病毒活性的杂环化合物。 特别地,式(I)化合物:其中B,W,X,Y,R 1,R 2,R 3,R 4和n如本文所定义,可用于治疗和预防哺乳动物中巨细胞病毒(CMV)感染。
-
-
-
-